Research outputs
2026
Comparative Effectiveness of Disease-Modifying Treatments in Double Seronegative Neuromyelitis Optica Spectrum Disorder
Mahler, J. V., Vallejos, G. B., Mikami, T., Bilodeau, P. A., Anderson, M., Drosu, N., . . . Matiello, M. (2026). Comparative Effectiveness of Disease-Modifying Treatments in Double Seronegative Neuromyelitis Optica Spectrum Disorder. NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 13(2). doi:10.1212/NXI.0000000000200514
Significant Visual Field Defects Persist Despite Excellent Visual Acuity Following Optic Neuritis in Myelin-Oligodendrocyte Glycoprotein Associated Disease.
Huda, S., Fineberg, A., Rocchi, C., Bialer, O., Klein, A., & Stiebel-Kalish, H. (2026). Significant Visual Field Defects Persist Despite Excellent Visual Acuity Following Optic Neuritis in Myelin-Oligodendrocyte Glycoprotein Associated Disease.. Neuro-ophthalmology (Aeolus Press), 50(1), 37-44. doi:10.1080/01658107.2025.2544335
The impact of relapse on patient disability, clinical outcomes, and subsequent burdens to patients with neuromyelitis optica spectrum disorder and caregivers
Huda, S., Kleman, M., Myren, K. -J., Unsworth, M., Castellano, G., Taskopru, B. K., & Fitzmaurice, K. (2026). The impact of relapse on patient disability, clinical outcomes, and subsequent burdens to patients with neuromyelitis optica spectrum disorder and caregivers. MULTIPLE SCLEROSIS JOURNAL-EXPERIMENTAL TRANSLATIONAL AND CLINICAL, 12(1). doi:10.1177/20552173251406973
2025
207 Diagnostic utility of brain biopsy in unexplained neurological disease: a retrospective cohort study
Shika, H., Sarah, H., Nikita, R., Saif, H., & John, W. (2025). 207 Diagnostic utility of brain biopsy in unexplained neurological disease: a retrospective cohort study. In 207 Diagnostic utility of brain biopsy in unexplained neurological disease: a retrospective cohort study (pp. A64.1-A64). BMJ Publishing Group Ltd. doi:10.1136/jnnp-2025-abn.207
A first report of progressive multifocal leukoencephalopathy in childhood-onset NMOSD
Siriratnam, P., Gosling, S., Bhojak, M., Griffiths, M., Kneen, R., Wassmer, E., & Huda, S. (2025). A first report of progressive multifocal leukoencephalopathy in childhood-onset NMOSD. MULTIPLE SCLEROSIS JOURNAL. doi:10.1177/13524585251331855
Treatment response in children with relapsing MOG-antibody associated disease.
Wendel, E. -M., Chen, J. J., Bertolini, A., Blaschek, A., Brilot, F., Dale, R. C., . . . BIOMARKER-Study group. (2025). Treatment response in children with relapsing MOG-antibody associated disease.. European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society, 59, 45-51. doi:10.1016/j.ejpn.2025.10.002
'Patients with rheumatological diseases should routinely be tested for aquaporin-4 (AQP4) antibodies': NO
Siriratnam, P., & Huda, S. (2025). 'Patients with rheumatological diseases should routinely be tested for aquaporin-4 (AQP4) antibodies': NO. MULTIPLE SCLEROSIS JOURNAL, 31(11), 1278-1280. doi:10.1177/13524585251367351
3621 Paediatric versus adult-onset neuromyelitis optica spectrum disorder: a multi-centre study
Siriratnam, P., Huda, S., Sanfilippo, P., Jokubaitis, V., Walt, A. V. D., Butzkueven, H., & Monif, M. (2025). 3621 Paediatric versus adult-onset neuromyelitis optica spectrum disorder: a multi-centre study. In Poster Abstracts (pp. A58.3-A58). BMJ Publishing Group Ltd. doi:10.1136/bmjno-2025-anzan.158
Thinking beyond papilloedema: importance of cells in the vitreous
Mbizvo, G. K., Visca, A., Huda, S., & Larner, A. J. (2025). Thinking beyond papilloedema: importance of cells in the vitreous. PRACTICAL NEUROLOGY, 25(5). doi:10.1136/pn-2024-004453
Unemployment, work hour reduction, and income loss: An international, multicentered, cross-sectional study of neuromyelitis optica spectrum disorder
Ham, A. S., Hjerthen, I. G., Tian, D. -C., Gu, H., Gao, W., Sudhir, A., . . . Mateen, F. J. (2025). Unemployment, work hour reduction, and income loss: An international, multicentered, cross-sectional study of neuromyelitis optica spectrum disorder. MULTIPLE SCLEROSIS JOURNAL, 31(11), 1358-1369. doi:10.1177/13524585251349139
Outcomes After Acute Plasma Exchange for Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease
Thakolwiboon, S., Redenbaugh, V., Chen, B., Hewitt, S., Shah, S., Lotan, I., . . . Chen, J. J. (2025). Outcomes After Acute Plasma Exchange for Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease. NEUROLOGY, 105(6). doi:10.1212/WNL.0000000000213903
Comorbidities Are Associated With Unfavorable Outcome in Aquaporin-4 Antibody Positive Neuromyelitis Optica Spectrum Disorders and Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: Exploratory Study From the CROCTINO Cohort.
Samadzadeh, S., Oertel, F. C., Salih, H., Lin, T. -Y., Motamedi, S., Chien, C., . . . Guthy Jackson Charitable Foundation – International Clinical Consortium and CROCTINO Collaborators. (2025). Comorbidities Are Associated With Unfavorable Outcome in Aquaporin-4 Antibody Positive Neuromyelitis Optica Spectrum Disorders and Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: Exploratory Study From the CROCTINO Cohort.. European journal of neurology, 32(6), e70214. doi:10.1111/ene.70214
Rituximab as First-Line Compared to Escalation Immunotherapy Is Associated With Lower Disability Accumulation in Aquaporin-4-IgG-Positive Neuromyelitis Optica Spectrum Disorder: A Multicenter Cohort Study From Germany and the United Kingdom
Engels, D., Rocchi, C., Forcadela, M., Siriratnam, P., Ringelstein, M., Huemmert, M. W., . . . Kuempfel, T. (2025). Rituximab as First-Line Compared to Escalation Immunotherapy Is Associated With Lower Disability Accumulation in Aquaporin-4-IgG-Positive Neuromyelitis Optica Spectrum Disorder: A Multicenter Cohort Study From Germany and the United Kingdom. EUROPEAN JOURNAL OF NEUROLOGY, 32(6). doi:10.1111/ene.70243
Progression independent of relapse activity and relapse-associated worsening in seronegative NMOSD: an international cohort study.
Siriratnam, P., Huda, S., Van der Walt, A., Sanfilippo, P., Sharmin, S., Foong, Y. C., . . . Monif, M. (2025). Progression independent of relapse activity and relapse-associated worsening in seronegative NMOSD: an international cohort study.. Journal of neurology, 272(5), 339. doi:10.1007/s00415-025-13064-6
Is a Benign Disease Course Possible in Untreated AQP4-IgG NMOSD?
Siriratnam, P., Rocchi, C., Gibbons, E., Kelly, P., Linaker, S., & Huda, S. (2025). Is a Benign Disease Course Possible in Untreated AQP4-IgG NMOSD?. EUROPEAN JOURNAL OF NEUROLOGY, 32(3). doi:10.1111/ene.70049
Opposing Influences of Optic Neuritis and Transverse Myelitis on the Future Location of Relapses in MOG Antibody-Associated Disease.
San Martin, D. L., Portela Filho, M. B., Rocchi, C., Hamid, S., & Huda, S. (2025). Opposing Influences of Optic Neuritis and Transverse Myelitis on the Future Location of Relapses in MOG Antibody-Associated Disease.. Brain and behavior, 15(3), e70127. doi:10.1002/brb3.70127
Advances in the therapeutic landscape for neuromyelitis optica spectrum disorder.
Chamberlain, J., Siriratnam, P., & Huda, S. (2025). Advances in the therapeutic landscape for neuromyelitis optica spectrum disorder.. Expert review of neurotherapeutics, 25(10), 1235-1256. doi:10.1080/14737175.2025.2548947
Lessons Learned: Quality Analysis of Optical Coherence Tomography in Neuromyelitis Optica.
Salih, H., Samadzadeh, S., Bereuter, C., Motamedi, S., Chien, C., Villoslada, P., . . . with the Guthy Jackson Charitable Foundation—International Clinical Consortium and CROCTINO Collaborators. (2025). Lessons Learned: Quality Analysis of Optical Coherence Tomography in Neuromyelitis Optica.. Annals of clinical and translational neurology. doi:10.1002/acn3.70235
Predictors of relapse risk and treatment response in AQP4-IgG positive and seronegative NMOSD: A multicentre study.
Siriratnam, P., Sanfilippo, P., van der Walt, A., Sharmin, S., Foong, Y. C., Yeh, W. Z., . . . MSBASE study group. (2025). Predictors of relapse risk and treatment response in AQP4-IgG positive and seronegative NMOSD: A multicentre study.. Journal of neurology, neurosurgery, and psychiatry, 96(4), 361-369. doi:10.1136/jnnp-2024-334090
2024
Prevalence of Progression Independent of Relapse Activity and Relapse-Associated Worsening in Patients With AQP4-IgG-Positive NMOSD
Siriratnam, P., Huda, S., van der Walt, A., Sanfilippo, P. G., Sharmin, S., Foong, Y. C., . . . Monif, M. (2024). Prevalence of Progression Independent of Relapse Activity and Relapse-Associated Worsening in Patients With AQP4-IgG-Positive NMOSD. NEUROLOGY, 103(12). doi:10.1212/WNL.0000000000209940
37. Underemployment, Work Hour Reduction, and Income Loss: A Global, Multi-centered, Cohort Study of Neuromyelitis Optica
Hjerthen, I. G., Hacker, C. T., Pandit, L., Sudhir, A., Shirkoohi, A., Rodriguez-Rivas, R., . . . Mateen, F. (2024). 37. Underemployment, Work Hour Reduction, and Income Loss: A Global, Multi-centered, Cohort Study of Neuromyelitis Optica. Multiple Sclerosis and Related Disorders, 92, 105998. doi:10.1016/j.msard.2024.105998
Employment, work hours, and wages in adults with myelin oligodendrocyte glycoprotein antibody disease: An international cohort study
Ham, A. S., Hjerthen, I. G., Sudhir, A., Pandit, L., Reddy, Y. M., Murthy, J. M., . . . Mateen, F. J. (2024). Employment, work hours, and wages in adults with myelin oligodendrocyte glycoprotein antibody disease: An international cohort study. MULTIPLE SCLEROSIS JOURNAL, 30(13), 1674-1682. doi:10.1177/13524585241286671
Study of seasonality of attacks in MOG antibody-associated disease
Francis, A., Santos, M., Rato, M. L., Wintle, Y. M., Brex, P., Chen, B., . . . Palace, J. (2024). Study of seasonality of attacks in MOG antibody-associated disease. MULTIPLE SCLEROSIS AND RELATED DISORDERS, 90. doi:10.1016/j.msard.2024.105814
Assessment of international MOGAD diagnostic criteria in patients with overlapping MOG-associated disease and multiple sclerosis phenotypes.
Manzano, G. S., Levy, M., Salky, R., Mateen, F. J., Klawiter, E. C., Chitnis, T., . . . Matiello, M. (2024). Assessment of international MOGAD diagnostic criteria in patients with overlapping MOG-associated disease and multiple sclerosis phenotypes.. Journal of neurology, 271(9), 6160-6171. doi:10.1007/s00415-024-12585-w
Characterizing mortality in patients with AQP4-Ab+ neuromyelitis optica spectrum disorder
Francis, A., Gibbons, E., Yu, J., Johnston, K., Rochon, H., Powell, L., . . . Palace, J. (2024). Characterizing mortality in patients with AQP4-Ab+ neuromyelitis optica spectrum disorder. ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 11(7), 1942-1947. doi:10.1002/acn3.52092
Impact of rituximab treatment regime on time to relapse in aquaporin-4 antibody positive neuromyelitis optica spectrum disorder
Nasir, M., Hone, L., Tallantyre, E., Kelly, P., Leite, M. I., Robertson, N., . . . Dobson, R. (2024). Impact of rituximab treatment regime on time to relapse in aquaporin-4 antibody positive neuromyelitis optica spectrum disorder. MULTIPLE SCLEROSIS AND RELATED DISORDERS, 85. doi:10.1016/j.msard.2024.105528
Relapse Determinants in Seropositive and Seronegative Neuromyelitis Optica Spectrum Disorder (P10-14.016)
Siriratnam, P., Sanfilippo, P., Huda, S., Sharmin, S., Kalincik, T., Van Der Walt, A., . . . Monif, M. (2024). Relapse Determinants in Seropositive and Seronegative Neuromyelitis Optica Spectrum Disorder (P10-14.016). Neurology, 102(7_supplement_1). doi:10.1212/wnl.0000000000205576
Predictors of azathioprine and mycophenolate mofetil response in patients with neuromyelitis optica spectrum disorder: A cohort study.
San Martin, D. L., Fukuda, T. G., Nascimento, T. S., Silva, M. B., Filho, M. B. P., Forcadela, M., . . . Oliveira-Filho, J. (2024). Predictors of azathioprine and mycophenolate mofetil response in patients with neuromyelitis optica spectrum disorder: A cohort study.. Multiple sclerosis and related disorders, 83, 105452. doi:10.1016/j.msard.2024.105452
The absence of antibodies in longitudinally extensive transverse myelitis may predict a more favourable prognosis
Rocchi, C., Forcadela, M., Kelly, P., Linaker, S., Gibbons, E., Bhojak, M., . . . Huda, S. (2024). The absence of antibodies in longitudinally extensive transverse myelitis may predict a more favourable prognosis. MULTIPLE SCLEROSIS JOURNAL, 30(3), 345-356. doi:10.1177/13524585231221664
Risks and outcomes of pregnancy in neuromyelitis optica spectrum disorder: A comprehensive review.
Siriratnam, P., Huda, S., Butzkueven, H., van der Walt, A., Jokubaitis, V., & Monif, M. (2024). Risks and outcomes of pregnancy in neuromyelitis optica spectrum disorder: A comprehensive review.. Autoimmunity reviews, 23(2), 103499. doi:10.1016/j.autrev.2023.103499
A retrospective multicenter study on clinical and serological parameters in patients with MuSK myasthenia gravis with and without general immunosuppression.
Koneczny, I., Mané-Damas, M., Zong, S., De Haas, S., Huda, S., van Kruining, D., . . . Martinez-Martinez, P. (2024). A retrospective multicenter study on clinical and serological parameters in patients with MuSK myasthenia gravis with and without general immunosuppression.. Frontiers in immunology, 15, 1325171. doi:10.3389/fimmu.2024.1325171
2023
A comprehensive review of the advances in neuromyelitis optica spectrum disorder
Siriratnam, P., Huda, S., Butzkueven, H., van der Walt, A., Jokubaitis, V., & Monif, M. (2023). A comprehensive review of the advances in neuromyelitis optica spectrum disorder. AUTOIMMUNITY REVIEWS, 22(12). doi:10.1016/j.autrev.2023.103465
Elsevier - Best clinical paper: Underemployment, work hour reduction, and income loss: A global, multi-centered, cohort study of neuromyelitis optica
Hjerthen, I. G., Hacker, C. T., Pandit, L., Sudhir, A., Shirkoohi, A., Rodriguez-Rivas, R., . . . Mateen, F. (2023). Elsevier - Best clinical paper: Underemployment, work hour reduction, and income loss: A global, multi-centered, cohort study of neuromyelitis optica. JOURNAL OF THE NEUROLOGICAL SCIENCES, 455. doi:10.1016/j.jns.2023.121066
Timing of MOG-IgG Testing Is Key to 2023 MOGAD Diagnostic Criteria
Forcadela, M., Rocchi, C., Martin, D. S., Gibbons, E. L., Wells, D., Woodhall, M. R., . . . Hamid, S. (2024). Timing of MOG-IgG Testing Is Key to 2023 MOGAD Diagnostic Criteria. NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 11(1). doi:10.1212/NXI.0000000000200183
Do we still need OCBs in MS diagnosis and how many?
Forcadela, M., Birch, K., Rocchi, C., Campagna, G., Jackson, E., Chadwick, C., . . . Huda, S. (2023). Do we still need OCBs in MS diagnosis and how many?. MULTIPLE SCLEROSIS AND RELATED DISORDERS, 79. doi:10.1016/j.msard.2023.105035
Treatment Response in Children with Relapsing MOGAD
Wendel, E. -M., Bertolini, A., Blaschek, A., Brilot, F., Chen, J. J., Dale, R., . . . Wendel, E. -M. (2023). Treatment Response in Children with Relapsing MOGAD. Neuropediatrics, 54(S 01), S1-S32. doi:10.1055/s-0043-1777154
Do Early Relapses Predict the Risk of Long-Term Relapsing Disease in an Adult and Paediatric Cohort with MOGAD?
Chen, B., Gomez-Figueroa, E., Redenbaugh, V., Francis, A., Satukijchai, C., Wu, Y., . . . Palace, J. (2023). Do Early Relapses Predict the Risk of Long-Term Relapsing Disease in an Adult and Paediatric Cohort with MOGAD?. ANNALS OF NEUROLOGY, 94(3), 508-517. doi:10.1002/ana.26731
IgG1-3 MuSK Antibodies Inhibit AChR Cluster Formation, Restored by SHP2 Inhibitor, Despite Normal MuSK, DOK7, or AChR Subunit Phosphorylation
Cao, M., Liu, W. -W., Maxwell, S., Huda, S., Webster, R., Evoli, A., . . . Vincent, A. (2023). IgG1-3 MuSK Antibodies Inhibit AChR Cluster Formation, Restored by SHP2 Inhibitor, Despite Normal MuSK, DOK7, or AChR Subunit Phosphorylation. NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 10(6). doi:10.1212/NXI.0000000000200147
Intravenous immunoglobulin treatment for acute attacks in myelin oligodendrocyte glycoprotein antibody disease
Lotan, I., Chen, J. J., Hacohen, Y., Abdel-Mannan, O., Mariotto, S., Huda, S., . . . Levy, M. (2023). Intravenous immunoglobulin treatment for acute attacks in myelin oligodendrocyte glycoprotein antibody disease. MULTIPLE SCLEROSIS JOURNAL, 29(9), 1080-1089. doi:10.1177/13524585231184738
It's not multiple sclerosis, what is it?!
Huda, S., & Palace, J. (2023). It's not multiple sclerosis, what is it?!. PRACTICAL NEUROLOGY, 23(4), 270-+. doi:10.1136/pn-2022-003677
Visual Outcomes Following Plasma Exchange for Optic Neuritis: An International Multicenter Retrospective Analysis of 395 Optic Neuritis Attacks
Chen, J. J., Flanagan, E. P., Pittock, S. J., Stern, N. C., Tisavipat, N., Bhatti, M. T., . . . Marignier, R. (2023). Visual Outcomes Following Plasma Exchange for Optic Neuritis: An International Multicenter Retrospective Analysis of 395 Optic Neuritis Attacks. AMERICAN JOURNAL OF OPHTHALMOLOGY, 252, 213-224. doi:10.1016/j.ajo.2023.02.013
Diagnostic value of intereye difference metrics for optic neuritis in aquaporin-4 antibody seropositive neuromyelitis optica spectrum disorders
Oertel, F. C., Zimmermann, H. G., Motamedi, S., Chien, C., Aktas, O., Albrecht, P., . . . Petzold, A. (2023). Diagnostic value of intereye difference metrics for optic neuritis in aquaporin-4 antibody seropositive neuromyelitis optica spectrum disorders. In JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY Vol. 94 (pp. 560-566). doi:10.1136/jnnp-2022-330608
International Delphi Consensus on the Management of AQP4-IgG+ NMOSD
Paul, F., Marignier, R., Palace, J., Arrambide, G., Asgari, N., Bennett, J. L., . . . Vaknin-Dembinsky, A. (2023). International Delphi Consensus on the Management of AQP4-IgG+ NMOSD. NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 10(4). doi:10.1212/NXI.0000000000200124
Most Opticospinal Demyelination is NMOSD, not MS-A 17-year UK Longitudinal Cohort Study
Forcadela, M., Rocchi, C., Panicker, J., Mutch, K., Huda, S., Jacob, A., & Hamid, S. (2023). Most Opticospinal Demyelination is NMOSD, not MS-A 17-year UK Longitudinal Cohort Study. In NEUROLOGY Vol. 100. doi:10.1212/WNL.0000000000203479
The absence of antibodies in longitudinally extensive transverse myelitis and the impact on prognosis
Rocchi, C., Forcadela, M., Jacob, A., Hamid, S., & Huda, S. (2023). The absence of antibodies in longitudinally extensive transverse myelitis and the impact on prognosis. In NEUROLOGY Vol. 100. doi:10.1212/WNL.0000000000203495
Acute Inflammatory Diseases of the Central Nervous System After SARS-CoV-2 Vaccination
Francis, A. G., Elhadd, K., Camera, V., dos Santos, M. F., Rocchi, C., Adib-Samii, P., . . . Palace, J. (2023). Acute Inflammatory Diseases of the Central Nervous System After SARS-CoV-2 Vaccination. NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 10(1). doi:10.1212/NXI.0000000000200063
Clinical and Imaging Features of Patients with Overlapping MOG-Associated Disease and Multiple Sclerosis
Manzano, G. S., Levy, M., Salky, R., Mateen, F. J., Klawiter, E. C., Chitnis, T., . . . Matiello, M. (2023). Clinical and Imaging Features of Patients with Overlapping MOG-Associated Disease and Multiple Sclerosis. In MULTIPLE SCLEROSIS JOURNAL Vol. 29 (pp. 162-163). Retrieved from https://www.webofscience.com/
2022
ACUTE INFLAMMATORY CNS DISEASES FOLLOWING VACCINATION AGAINST SARS-COV-2
Francis, A., Camera, V., Elhadd, K., Craner, M., Attfield, K., Iversen, A., . . . Palace, J. (2022). ACUTE INFLAMMATORY CNS DISEASES FOLLOWING VACCINATION AGAINST SARS-COV-2. In JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY Vol. 93. doi:10.1136/jnnp-2022-abn2.20
IMPACT OF RITUXIMAB REGIME ON TIME TO RELAPSE IN AQUAPORIN-4 ANTIBODY POSITIVE NEUROMYELITIS SPECTRUM DISORDER
Nasir, M., Hone, L., Palace, J., Tallantyre, E., Kelly, P., Isabel Leite, M., . . . Dobson, R. (2022). IMPACT OF RITUXIMAB REGIME ON TIME TO RELAPSE IN AQUAPORIN-4 ANTIBODY POSITIVE NEUROMYELITIS SPECTRUM DISORDER. In JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY Vol. 93. doi:10.1136/jnnp-2022-abn2.29
Longitudinal Retinal Changes in MOGAD.
Oertel, F. C., Sotirchos, E. S., Zimmermann, H. G., Motamedi, S., Specovius, S., Asseyer, E. S., . . . with the GJCF International Clinical Consortium for NMOSD and the CROCTINO study group. (2022). Longitudinal Retinal Changes in MOGAD.. Annals of neurology, 92(3), 476-485. doi:10.1002/ana.26440
Progressive myelin oligodendrocyte glycoprotein-associated demyelination mimicking leukodystrophy
Gibbons, E., Whittam, D., Elhadd, K., Bhojak, M., Rathi, N., Avula, S., . . . Huda, S. (2022). Progressive myelin oligodendrocyte glycoprotein-associated demyelination mimicking leukodystrophy. MULTIPLE SCLEROSIS JOURNAL, 28(9), 1481-1484. doi:10.1177/13524585221090737
Rituximab abrogates aquaporin-4-specific germinal center activity in patients with neuromyelitis optica spectrum disorders
Damato, V., Theorell, J., Al-Diwani, A., Kienzler, A. -K., Makuch, M., Sun, B., . . . Irani, S. R. (2022). Rituximab abrogates aquaporin-4-specific germinal center activity in patients with neuromyelitis optica spectrum disorders. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 119(24). doi:10.1073/pnas.2121804119
069 Co-existent autoimmune disease in AQP4-IgG, MOG-IgG and seronegative NMOSD
Linaker, S., Kelly, P., Gibbons, E., Campagna, G., Whittam, D., Karthikeayan, V. -M., . . . Huda, S. (2022). 069 Co-existent autoimmune disease in AQP4-IgG, MOG-IgG and seronegative NMOSD. Journal of Neurology, Neurosurgery & Psychiatry, 93(6), A34.1-A34. doi:10.1136/jnnp-2022-abn.106
070 What is seronegative neuromyelitis optica spectrum disorder?
Gibbons, E., Campgana, G., O’Connell, K., Yeo, T., Whittam, D., Karthikeayan, V. -M., . . . Huda, S. (2022). 070 What is seronegative neuromyelitis optica spectrum disorder?. Journal of Neurology, Neurosurgery & Psychiatry, 93(6), A34.2-A34. doi:10.1136/jnnp-2022-abn.107
071 Causes of death in AQP4-IgG neuromyelitis optica spectrum disorder
Gibbons, E., Everett, R., Whittam, D., Karthikeayan, V., Messina, S., Radu, S., . . . Jacob, A. (2022). 071 Causes of death in AQP4-IgG neuromyelitis optica spectrum disorder. Journal of Neurology, Neurosurgery & Psychiatry, 93(6), A34.3-A34. doi:10.1136/jnnp-2022-abn.108
A wolf in sheep’s clothing
Gibbons, E., Whittam, D., Karthikeayan, V., Campagna, G., Wong, S., Yu-Wai-Man, P., . . . Jacob, A. (2022). A wolf in sheep’s clothing. Journal of Neurology, Neurosurgery & Psychiatry, 93(6), A13.3-A14. doi:10.1136/jnnp-2022-abn.39
Do we still need OCBs in MS diagnosis and how many?
Campagna, G., Birch, K., Gibbons, E., Jackson, E., Chadwick, C., Ellul, M., . . . Huda, S. (2022). Do we still need OCBs in MS diagnosis and how many?. Journal of Neurology, Neurosurgery & Psychiatry, 93(6), A12.1-A12. doi:10.1136/jnnp-2022-abn.34
Prognostic indicators and outcomes of hospitalised COVID-19 patients with neurological disease: An individual patient data meta-analysis
Singh, B., Lant, S., Cividini, S., Cattrall, J. W. S., Goodwin, L. C., Benjamin, L., . . . Solomon, T. (2022). Prognostic indicators and outcomes of hospitalised COVID-19 patients with neurological disease: An individual patient data meta-analysis. PLOS ONE, 17(6). doi:10.1371/journal.pone.0263595
Association of Maintenance Intravenous Immunoglobulin With Prevention of Relapse in Adult Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease
Chen, J. J., Huda, S., Hacohen, Y., Levy, M., Lotan, I., Wilf-Yarkoni, A., . . . Marignier, R. (2022). Association of Maintenance Intravenous Immunoglobulin With Prevention of Relapse in Adult Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease. JAMA NEUROLOGY, 79(5), 518-525. doi:10.1001/jamaneurol.2022.0489
Health utilities and costs for neuromyelitis optica spectrum disorder
Hughes, D. A., Bourke, S., Jones, A., Bhatt, R., Huda, S., Mutch, K., & Jacob, A. (2022). Health utilities and costs for neuromyelitis optica spectrum disorder. ORPHANET JOURNAL OF RARE DISEASES, 17(1). doi:10.1186/s13023-022-02310-z
Symptomatic and restorative therapies in neuromyelitis optica spectrum disorders.
Abboud, H., Salazar-Camelo, A., George, N., Planchon, S. M., Matiello, M., Mealy, M. A., . . . On-behalf of the Guthy-Jackson Foundation NMO International Clinical Consortium. (2022). Symptomatic and restorative therapies in neuromyelitis optica spectrum disorders.. Journal of neurology, 269(4), 1786-1801. doi:10.1007/s00415-021-10783-4
Astrocytic outer retinal layer thinning is not a feature in AQP4-IgG seropositive neuromyelitis optica spectrum disorders
Lu, A., Zimmermann, H. G., Specovius, S., Motamedi, S., Chien, C., Bereuter, C., . . . Oertel, F. C. (2022). Astrocytic outer retinal layer thinning is not a feature in AQP4-IgG seropositive neuromyelitis optica spectrum disorders. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 93(2), 188-195. doi:10.1136/jnnp-2021-327412
Factors Associated With Relapse and Treatment of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease in the United Kingdom
Satukijchai, C., Mariano, R., Messina, S., Sa, M., Woodhall, M. R., Robertson, N. P., . . . Palace, J. (2022). Factors Associated With Relapse and Treatment of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease in the United Kingdom. JAMA NETWORK OPEN, 5(1). doi:10.1001/jamanetworkopen.2021.42780
Early predictors of disability of paediatric-onset AQP4-IgG-seropositive neuromyelitis optica spectrum disorders
Camera, V., Messina, S., Elhadd, K. T., Sanpera-Iglesias, J., Mariano, R., Hacohen, Y., . . . Palace, J. (2022). Early predictors of disability of paediatric-onset AQP4-IgG-seropositive neuromyelitis optica spectrum disorders. In JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY Vol. 93 (pp. 101-111). doi:10.1136/jnnp-2021-327206
Most opticospinal demyelination is NMOSD, not MS - a 17-year UK longitudinal cohort study
Forcadela, M., Rocchi, C., Panicker, J., Das, K., Elsone, L., Mutch, K., . . . Hamid, S. (2022). Most opticospinal demyelination is NMOSD, not MS - a 17-year UK longitudinal cohort study. In MULTIPLE SCLEROSIS JOURNAL Vol. 28 (pp. 142). Retrieved from https://www.webofscience.com/
N-Methyl-D-Aspartate receptor and myelin oligodendrocyte glycoprotein antibody overlap syndrome with homonymous hemianopia: A case report
Ali, O., Elhadd, K. T., Mirasol, F., Chiara, R., Lyons-Nandra, S., Hamid, S., . . . Huda, S. (2022). N-Methyl-D-Aspartate receptor and myelin oligodendrocyte glycoprotein antibody overlap syndrome with homonymous hemianopia: A case report. Neuroimmunology Reports, 2, 100149. doi:10.1016/j.nerep.2022.100149
Predicting the risk of long-term relapse in MOGAD
Francis, A., Gomez, E., Chen, B., Woodhall, M., Blain, C., Cooper, S., . . . Palace, J. (2022). Predicting the risk of long-term relapse in MOGAD. In MULTIPLE SCLEROSIS JOURNAL Vol. 28 (pp. 146-147). Retrieved from https://www.webofscience.com/
Role of complement and potential of complement inhibitors in myasthenia gravis and neuromyelitis optica spectrum disorders: a brief review (vol 268, pg 1643, 2021)
Chamberlain, J. L., Huda, S., Whittam, D. H., Matiello, M., Morgan, B. P., & Jacob, A. (2021). Role of complement and potential of complement inhibitors in myasthenia gravis and neuromyelitis optica spectrum disorders: a brief review (vol 268, pg 1643, 2021). JOURNAL OF NEUROLOGY. doi:10.1007/s00415-021-10896-w
The absence of antibodies in longitudinally extensive transverse myelitis may predict a favourable prognosis
Rocchi, C., Forcadela, M., Jacob, A., Hamid, S., & Huda, S. (2022). The absence of antibodies in longitudinally extensive transverse myelitis may predict a favourable prognosis. In MULTIPLE SCLEROSIS JOURNAL Vol. 28 (pp. 43). Retrieved from https://www.webofscience.com/
Treatment of myelin oligodendrocyte glycoprotein antibody associated disease with subcutaneous immune globulin
Sotirchos, E., Vasileiou, E., Salky, R., Huda, S., Mariotto, S., Chen, J., & Levy, M. (2022). Treatment of myelin oligodendrocyte glycoprotein antibody associated disease with subcutaneous immune globulin. In MULTIPLE SCLEROSIS JOURNAL Vol. 28 (pp. 153). Retrieved from https://www.webofscience.com/
Treatment of myelin oligodendrocyte glycoprotein antibody associated disease with subcutaneous immune globulin
Sotirchos, E. S., Vasileiou, E. S., Salky, R., Huda, S., Mariotto, S., Chen, J. J., & Levy, M. (2022). Treatment of myelin oligodendrocyte glycoprotein antibody associated disease with subcutaneous immune globulin. MULTIPLE SCLEROSIS AND RELATED DISORDERS, 57. doi:10.1016/j.msard.2021.103462
2021
A case series of intracranial dural arteriovenous fistulae mimicking cervical myelitis: a diagnosis not to be missed
Whittam, D., Huda, S., Gibbons, E., Pullicino, R., Solomon, T., Chandran, A., . . . Jacob, A. (2021). A case series of intracranial dural arteriovenous fistulae mimicking cervical myelitis: a diagnosis not to be missed. JOURNAL OF NEUROLOGY, 268(12), 4680-4686. doi:10.1007/s00415-021-10571-0
Predictors of relapse in MOG antibody associated disease: a cohort study
Huda, S., Whittam, D., Jackson, R., Karthikeayan, V., Kelly, P., Linaker, S., . . . Jacob, A. (2021). Predictors of relapse in MOG antibody associated disease: a cohort study. BMJ OPEN, 11(11). doi:10.1136/bmjopen-2021-055392
Retinal Optical Coherence Tomography in Neuromyelitis Optica
Oertel, F. C., Specovius, S., Zimmermann, H. G., Chien, C., Motamedi, S., Bereuter, C., . . . Paul, F. (2021). Retinal Optical Coherence Tomography in Neuromyelitis Optica. NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 8(6). doi:10.1212/NXI.0000000000001068
Images of the month 1: Trident sign and neurosarcoidosis
Gibbons, E., Whittam, D., Jacob, A., & Huda, S. (2021). Images of the month 1: Trident sign and neurosarcoidosis. CLINICAL MEDICINE, 21(6), E667-E668. doi:10.7861/clinmed.2021-0596
SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study
Schache, A. (2021). SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study. British Journal of Surgery, 108(9), 1056-1063. doi:10.1093/bjs/znab101
No strong HLA association with MOG antibody disease in the UK population
Grant-Peters, M., Passos, G. R. D., Yeung, H. -Y., Jacob, A., Huda, S., Leite, M. I., . . . Palace, J. (2021). No strong HLA association with MOG antibody disease in the UK population. ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 8(7), 1502-1507. doi:10.1002/acn3.51378
Retigabine add-on for refractory partial-onset seizures
Huda, S., Shukralla, A., & Marson, A. G. (2021). Retigabine add-on for refractory partial-onset seizures. Cochrane Database of Systematic Reviews, 2021(6). doi:10.1002/14651858.cd009368.pub2
Long-Term Safety and Efficacy of Eculizumab in Aquaporin-4 IgG-Positive NMOSD.
Wingerchuk, D. M., Fujihara, K., Palace, J., Berthele, A., Levy, M., Kim, H. J., . . . PREVENT Study Group. (2021). Long-Term Safety and Efficacy of Eculizumab in Aquaporin-4 IgG-Positive NMOSD.. Annals of neurology, 89(6), 1088-1098. doi:10.1002/ana.26049
Role of complement and potential of complement inhibitors in myasthenia gravis and neuromyelitis optica spectrum disorders: a brief review
Chamberlain, J. L., Huda, S., Whittam, D. H., Matiello, M., Morgan, B. P., & Jacob, A. (2021). Role of complement and potential of complement inhibitors in myasthenia gravis and neuromyelitis optica spectrum disorders: a brief review. JOURNAL OF NEUROLOGY, 268(5), 1643-1664. doi:10.1007/s00415-019-09498-4
Role of complement and potential of complement inhibitors in myasthenia gravis and neuromyelitis optica spectrum disorders: a brief review (pg 1, 2019)
Chamberlain, J. L., Huda, S., Whittam, D. H., Matiello, M., Morgan, B. P., & Jacob, A. (2021). Role of complement and potential of complement inhibitors in myasthenia gravis and neuromyelitis optica spectrum disorders: a brief review (pg 1, 2019). JOURNAL OF NEUROLOGY, 268(5), 1665. doi:10.1007/s00415-019-09568-7
Treatment of myelin oligodendrocyte glycoprotein immunoglobulin G–associated disease
Healy, S., Elhadd, K. T., Gibbons, E., Whittam, D., Griffiths, M., Jacob, A., & Huda, S. (2021). Treatment of myelin oligodendrocyte glycoprotein immunoglobulin G–associated disease. Clinical and Experimental Neuroimmunology, 12(1), 22-41. doi:10.1111/cen3.12630
Absence of astrocytic outer retinal layer thinning in AQP4-IgG seropositive neuromyelitis optica spectrum disorders
Lu, A., Zimmermann, H. G., Specovius, S., Motamedi, S., Chien, C., Lana-Peixoto, M. A., . . . Oertel, F. C. (2021). Absence of astrocytic outer retinal layer thinning in AQP4-IgG seropositive neuromyelitis optica spectrum disorders. In MULTIPLE SCLEROSIS JOURNAL Vol. 27 (pp. 493-495). Retrieved from https://www.webofscience.com/
International multicenter retrospective study suggests maintenance intravenous immunoglobulin is effective in preventing relapse in adults with myelin oligodendrocyte glycoprotein antibody associated disorder
Chen, J., Huda, S., Hacohen, Y., Levy, M., Lotan, I., Hellmann, M., . . . Marignier, R. (2021). International multicenter retrospective study suggests maintenance intravenous immunoglobulin is effective in preventing relapse in adults with myelin oligodendrocyte glycoprotein antibody associated disorder. In MULTIPLE SCLEROSIS JOURNAL Vol. 27 (pp. 548-550). Retrieved from https://www.webofscience.com/
The characterisation of sleep and circadian rhythm in neuromyelitis optica
Elhadd, K., Healy, S., Gibbons, E., Kelly, P., Linaker, S., Manuel, A., & Huda, S. (2021). The characterisation of sleep and circadian rhythm in neuromyelitis optica. Medical Research Archives, 9(10). doi:10.18103/mra.v9i10.2552
2020
Case Report: Myelin Oligodendrocyte Glycoprotein Antibody-Associated Relapse With COVID-19
Woodhall, M., Mitchell, J. W., Gibbons, E., Healy, S., Waters, P., & Huda, S. (2020). Case Report: Myelin Oligodendrocyte Glycoprotein Antibody-Associated Relapse With COVID-19. FRONTIERS IN NEUROLOGY, 11. doi:10.3389/fneur.2020.598531
Cohort profile: a collaborative multicentre study of retinal optical coherence tomography in 539 patients with neuromyelitis optica spectrum disorders (CROCTINO)
Specovius, S., Zimmermann, H. G., Oertel, F. C., Chien, C., Bereuter, C., Cook, L. J., . . . Paul, F. (2020). Cohort profile: a collaborative multicentre study of retinal optical coherence tomography in 539 patients with neuromyelitis optica spectrum disorders (CROCTINO). BMJ OPEN, 10(10). doi:10.1136/bmjopen-2019-035397
Treatment of MOG-IgG-associated disorder with rituximab: An international study of 121 patients.
Whittam, D. H., Cobo-Calvo, A., Lopez-Chiriboga, A. S., Pardo, S., Gornall, M., Cicconi, S., . . . Jacob, A. (2020). Treatment of MOG-IgG-associated disorder with rituximab: An international study of 121 patients.. Multiple sclerosis and related disorders, 44. doi:10.1016/j.msard.2020.102251
Treatment of MOG antibody associated disorders: results of an international survey
Whittam, D. H., Karthikeayan, V., Gibbons, E., Kneen, R., Chandratre, S., Ciccarelli, O., . . . Jacob, A. (2020). Treatment of MOG antibody associated disorders: results of an international survey. Journal of Neurology, 2020. doi:10.1007/s00415-020-10026-y
SHP2 inhibitor protects AChRs from effects of myasthenia gravis MuSK antibody
Huda, S., Cao, M., De Rosa, A., Woodhall, M., Rodriguez Cruz, P. M., Cossins, J., . . . Vincent, A. (2020). SHP2 inhibitor protects AChRs from effects of myasthenia gravis MuSK antibody. NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 7(1). doi:10.1212/NXI.0000000000000645
Immunological mechanisms for the efficacy of Rituximab in aquaporin-4 autoantibody mediated Neuromyelitis Optica spectrum disorders
Damato, V., Theorell, J., Al-Diwani, A., Sun, B., Whittam, D., Huda, S., . . . Irani, S. (2020). Immunological mechanisms for the efficacy of Rituximab in aquaporin-4 autoantibody mediated Neuromyelitis Optica spectrum disorders. In EUROPEAN JOURNAL OF NEUROLOGY Vol. 27 (pp. 74). Retrieved from https://www.webofscience.com/
Optical coherence tomography in aquaporin-4-IgG positive neuromyelitis optica spectrum disorders: a collaborative multi-center study
Oertel, F. C., Specovius, S., Zimmermann, H., Chien, C., Motamedi, S., Cook, L., . . . Paul, F. (2020). Optical coherence tomography in aquaporin-4-IgG positive neuromyelitis optica spectrum disorders: a collaborative multi-center study. In MULTIPLE SCLEROSIS JOURNAL Vol. 26 (pp. 33-34). Retrieved from https://www.webofscience.com/
The clinical spectrum of movement disorders associated with neuronal antibodies
Karthikeayan, V., Randall, A., Jackson, E., Huda, S., & Bonello, M. (2020). The clinical spectrum of movement disorders associated with neuronal antibodies. In MOVEMENT DISORDERS Vol. 35 (pp. S134). Retrieved from https://www.webofscience.com/
What is seronegative neuromyelitis optica spectrum disorder?
Gibbons, E., Campagna, G., O'Connell, K., Yeo, T., Whittam, D., Leite, M., . . . Huda, S. (2020). What is seronegative neuromyelitis optica spectrum disorder?. In MULTIPLE SCLEROSIS JOURNAL Vol. 26 (pp. 482). Retrieved from https://www.webofscience.com/
2019
COMPARISON OF FIXED HIGH DOSE WITH VARIABLE LOW DOSE RITUXIMAB IN NEUROMYELITIS OPTICA SPECTRUM DISORDERS
Kelly, P., Whittam, D., Linaker, S., Mutch, K., Karthikeayan, V., Huda, S., & Jacob, A. (2019). COMPARISON OF FIXED HIGH DOSE WITH VARIABLE LOW DOSE RITUXIMAB IN NEUROMYELITIS OPTICA SPECTRUM DISORDERS. In JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY Vol. 90 (pp. E16). doi:10.1136/jnnp-2019-ABN-2.27
LATE ONSET MULTIPLE SCLEROSIS IN NORTH WALES
Karthikeayan, V., Copeland, Y., Fearn, C., Whittam, D., Elsone, L., Huda, S., & Jacob, A. (2019). LATE ONSET MULTIPLE SCLEROSIS IN NORTH WALES. In JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY Vol. 90 (pp. E8). doi:10.1136/jnnp-2019-ABN-2.2
MULTIPLE SCLEROSIS ASSOCIATED WITH PSORIASIS - IS ALEMTUZUMAB THE DRUG OF CHOICE?
Karthikeayan, V., Whittam, D., Copeland, Y., Huda, S., & Jacob, A. (2019). MULTIPLE SCLEROSIS ASSOCIATED WITH PSORIASIS - IS ALEMTUZUMAB THE DRUG OF CHOICE?. In JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY Vol. 90 (pp. E57). doi:10.1136/jnnp-2019-ABN-2.161
Intracranial dural arteriovenous fistula mistaken as cervical transverse myelitis
Peethambar, G. A., Whittam, D. H., Huda, S., Alusi, S., Puthuran, M., Chandran, A., . . . Jacob, A. (2019). Intracranial dural arteriovenous fistula mistaken as cervical transverse myelitis. PRACTICAL NEUROLOGY, 19(3), 264-267. doi:10.1136/practneurol-2018-002091
Nitrous oxide myelopathy with functional vitamin <sub>B</sub> <sub>12</sub> deficiency
Williamson, J., Huda, S., & Damodaran, D. (2019). Nitrous oxide myelopathy with functional vitamin <sub>B</sub> <sub>12</sub> deficiency. BMJ CASE REPORTS, 12(2). doi:10.1136/bcr-2018-227439
Rituximab in neurological disease: principles, evidence and practice
Whittam, D. H., Tallantyre, E. C., Jolles, S., Huda, S., Moots, R. J., Kim, H. J., . . . Jacob, A. (2019). Rituximab in neurological disease: principles, evidence and practice. PRACTICAL NEUROLOGY, 19(1), 5-20. doi:10.1136/practneurol-2018-001899
An international retrospective multi-center study of retinal optical coherence tomography in neuromyelitis optica spectrum disorders: the CROCTINO study
Oertel, F. C., Specovius, S., Zimmermann, H. G., Chien, C., Motamedi, S., Cook, L., . . . Paul, F. (2019). An international retrospective multi-center study of retinal optical coherence tomography in neuromyelitis optica spectrum disorders: the CROCTINO study. In MULTIPLE SCLEROSIS JOURNAL Vol. 25 (pp. 709-711). Retrieved from https://www.webofscience.com/
Causes of death in AQP4-IgG neuromyelitis optica spectrum disorder (NMOSD) in the United Kingdom NMOSD Service
Gibbons, E., Everett, R., Whittam, D., Karthikeayan, V., Messina, S., Mutch, K., . . . Jacob, A. (2019). Causes of death in AQP4-IgG neuromyelitis optica spectrum disorder (NMOSD) in the United Kingdom NMOSD Service. In MULTIPLE SCLEROSIS JOURNAL Vol. 25 (pp. 588-589). Retrieved from https://www.webofscience.com/
Immunological insights into the mechanisms by which RTX is effective in Neuromyelitis Optica spectrum disorders
Damato, V., Whittam, D., Huda, S., Woodhall, M., Waters, P., Jacob, A., & Irani, S. R. (2019). Immunological insights into the mechanisms by which RTX is effective in Neuromyelitis Optica spectrum disorders. In EUROPEAN JOURNAL OF NEUROLOGY Vol. 26 (pp. 23). Retrieved from https://www.webofscience.com/
Intravenous immunoglobulin as a maintenance immunotherapy in refractory Myelin Oligodendrocyte Glycoprotein-Antibody associated disorder
Karthikeayan, V., Whittam, D., Gibbons, E., Kelly, P., Linaker, S., Mutch, K., . . . Jacob, A. (2019). Intravenous immunoglobulin as a maintenance immunotherapy in refractory Myelin Oligodendrocyte Glycoprotein-Antibody associated disorder. In MULTIPLE SCLEROSIS JOURNAL Vol. 25 (pp. 369). Retrieved from https://www.webofscience.com/
Neuromyelitis optica spectrum disorders
Huda, S., Whittam, D., Bhojak, M., Chamberlain, J., Noonan, C., & Jacob, A. (2019). Neuromyelitis optica spectrum disorders. CLINICAL MEDICINE, 19(2), 169-176. doi:10.7861/clinmedicine.19-2-169
Steroid refractory giant cell arteritis with bilateral vertebral artery occlusion and middle cerebellar peduncle infarction
Healy, S., Simpson, M., Kitchen, W. J., Jacob, A., Crooks, D., Rathi, N., . . . Sekhar, A. (2019). Steroid refractory giant cell arteritis with bilateral vertebral artery occlusion and middle cerebellar peduncle infarction. JOURNAL OF THE ROYAL COLLEGE OF PHYSICIANS OF EDINBURGH, 49(2), 118-121. doi:10.4997/JRCPE.2019.206
2018
MRI ABNORMALITIES IN MOG ANTIBODY DISEASE
Huda, S., Al-Orainy, A., Saldanha, A., Whittam, D., Denby, C., Pandit, L., . . . Jacob, A. (2018). MRI ABNORMALITIES IN MOG ANTIBODY DISEASE. In JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY Vol. 89. doi:10.1136/jnnp-2018-ABN.153
NMDAR-AB ENCEPHALITIS: FREQUENCY OF DIAGNOSIS AND OUTCOMES
Lim, H., Whittam, D., Jackson, E., Williams, N., O'Connell, D., Chadwick, C., . . . Jacob, A. (2018). NMDAR-AB ENCEPHALITIS: FREQUENCY OF DIAGNOSIS AND OUTCOMES. In JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY Vol. 89. doi:10.1136/jnnp-2018-ABN.66
Autoimmune encephalitis (NMDAR antibody) in a patient receiving chronic post-transplant immunosuppression.
Randall, A., Huda, S., Jacob, A., & Larner, A. J. (2018). Autoimmune encephalitis (NMDAR antibody) in a patient receiving chronic post-transplant immunosuppression.. Practical neurology, 18(4), 320-322. doi:10.1136/practneurol-2018-001923
Serological and experimental studies in different forms of myasthenia gravis
Vincent, A., Huda, S., Cao, M., Cetin, H., Koneczny, I., Rodriguez-Cruz, P., . . . Beeson, D. (2018). Serological and experimental studies in different forms of myasthenia gravis. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1413(1), 143-153. doi:10.1111/nyas.13592
The CROCTINO project: an international retrospective multi-center study of retinal optical coherence tomography in 501 patients with neuromyelitis optica spectrum disorders
Specovius, S., Zimmermann, H. G., Chien, C., Oertel, F. C., Cooke, L., Martinez-Lapiscina, E. H., . . . Paul, F. (2018). The CROCTINO project: an international retrospective multi-center study of retinal optical coherence tomography in 501 patients with neuromyelitis optica spectrum disorders. In MULTIPLE SCLEROSIS JOURNAL Vol. 24 (pp. 642-644). Retrieved from https://www.webofscience.com/
2017
A BLUNT OCKHAM'S RAZOR: NMDARE AND LYMPHOMA POST IMMUNOSUPPRESSION
Randall, A., Huda, S., Jacob, A., & Larner, A. (2017). A BLUNT OCKHAM'S RAZOR: NMDARE AND LYMPHOMA POST IMMUNOSUPPRESSION. In JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY Vol. 88 (pp. A76). doi:10.1136/jnnp-2017-ABN.262
SHP2 INHIBITION ALLEVIATES THE PATHOGENIC EFFECTS OF MUSK ANTIBODIES
Huda, S., Michelangelo, C., Anna, D. R., Mark, W., Judith, C., Michelangelo, M., . . . Angela, V. (2017). SHP2 INHIBITION ALLEVIATES THE PATHOGENIC EFFECTS OF MUSK ANTIBODIES. In JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY Vol. 88 (pp. A64). doi:10.1136/jnnp-2017-ABN.221
Inhibition of the tyrosine phosphatase Shp2 alleviates the pathogeniceff ects of MuSK antibodies in vitro
Huda, S., Cao, M., De Rosa, A., Woodhall, M., Cossins, J., Maestri, M., . . . Vincent, A. (2017). Inhibition of the tyrosine phosphatase Shp2 alleviates the pathogeniceff ects of MuSK antibodies in vitro. Neuromuscular Disorders, 27, S36. doi:10.1016/s0960-8966(17)30325-5
IgG4 autoantibodies against muscle-specific kinase undergo Fab-arm exchange in myasthenia gravis patients
Koneczny, I., Stevens, J. A. A., De Rosa, A., Huda, S., Huijbers, M. G., Saxena, A., . . . Losen, M. (2017). IgG4 autoantibodies against muscle-specific kinase undergo Fab-arm exchange in myasthenia gravis patients. JOURNAL OF AUTOIMMUNITY, 77, 104-115. doi:10.1016/j.jaut.2016.11.005
IgG-specific cell-based assay detects potentially pathogenic MuSK-Abs in seronegative MG
Huda, S., Waters, P., Woodhall, M., Leite, M. I., Jacobson, L., De Rosa, A., . . . Vincent, A. (2017). IgG-specific cell-based assay detects potentially pathogenic MuSK-Abs in seronegative MG. NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 4(4). doi:10.1212/NXI.0000000000000357
2016
CHARACTERISTICS OF ACETYLCHOLINE-RECEPTOR-ANTIBODY-NEGATIVE MYASTHENIA GRAVIS IN A SOUTH AFRICAN COHORT
Huda, S., Woodhall, M. R., Vincent, A., & Heckmann, J. M. (2016). CHARACTERISTICS OF ACETYLCHOLINE-RECEPTOR-ANTIBODY-NEGATIVE MYASTHENIA GRAVIS IN A SOUTH AFRICAN COHORT. MUSCLE & NERVE, 54(6), 1023-1029. doi:10.1002/mus.25154
Nurse led telephone assessment of expanded disability status scale assessment in MS patients at high levels of disability
Huda, S., Cavey, A., Izat, A., Mattison, P., Boggild, M., & Palace, J. (2016). Nurse led telephone assessment of expanded disability status scale assessment in MS patients at high levels of disability. JOURNAL OF THE NEUROLOGICAL SCIENCES, 362, 66-68. doi:10.1016/j.jns.2016.01.011
2015
Use of cell-based assays in myasthenia gravis and other antibody-mediated diseases
Cruz, P. M. R., Huda, S., Lopez-Ruiz, P., & Vincent, A. (2015). Use of cell-based assays in myasthenia gravis and other antibody-mediated diseases. EXPERIMENTAL NEUROLOGY, 270, 66-71. doi:10.1016/j.expneurol.2015.01.011
Clinical Features and Diagnostic Usefulness of Antibodies to Clustered Acetylcholine Receptors in the Diagnosis of Seronegative Myasthenia Gravis
Cruz, P. M. R., Al-Hajjar, M., Huda, S., Jacobson, L., Woodhall, M., Jayawant, S., . . . Palace, J. (2015). Clinical Features and Diagnostic Usefulness of Antibodies to Clustered Acetylcholine Receptors in the Diagnosis of Seronegative Myasthenia Gravis. JAMA NEUROLOGY, 72(6), 642-649. doi:10.1001/jamaneurol.2015.0203
An 11-year retrospective experience of antibodies against the voltage-gated potassium channel (VGKC) complex from a tertiary neurological centre
Huda, S., Wong, S. H., Pettingill, P., O'Connell, D., Vincent, A., & Steiger, M. (2015). An 11-year retrospective experience of antibodies against the voltage-gated potassium channel (VGKC) complex from a tertiary neurological centre. JOURNAL OF NEUROLOGY, 262(2), 418-424. doi:10.1007/s00415-014-7588-0
2014
O'Sullivan-McLeod syndrome: clinical features, neuroradiology and nosology
Ghadiri-Sani, M., Huda, S., & Larner, A. J. (2014). O'Sullivan-McLeod syndrome: clinical features, neuroradiology and nosology. BRITISH JOURNAL OF HOSPITAL MEDICINE, 75(12), 712-713. doi:10.12968/hmed.2014.75.12.712
SERONEGATIVE MYASTHENIA GRAVIS-CLINICAL/SEROLOGICAL ASPECTS
Huda, S., Koneczny, I., Jacobsen, L., Beeson, D., & Vincent, A. (2014). SERONEGATIVE MYASTHENIA GRAVIS-CLINICAL/SEROLOGICAL ASPECTS. Journal of Neurology, Neurosurgery & Psychiatry, 85(10), e4.86-e4. doi:10.1136/jnnp-2014-309236.176
P45 Seronegative myasthenia gravis – clinical and serological features
Huda, S., Koneczny, I., Jacobsen, L., Beeson, D., & Vincent, A. (2014). P45 Seronegative myasthenia gravis – clinical and serological features. Neuromuscular Disorders, 24, S19. doi:10.1016/s0960-8966(14)70061-6
Acetylcholine Receptor and Muscle-Specific Kinase Autoantibodies
Huda, S., & Vincent, A. (2014). Acetylcholine Receptor and Muscle-Specific Kinase Autoantibodies. In Autoantibodies (pp. 575-580). Elsevier. doi:10.1016/b978-0-444-56378-1.00068-x
Ocular Myasthenia Gravis: Controversies and Updates
Wong, S. H., Huda, S., Vincent, A., & Plant, G. T. (2014). Ocular Myasthenia Gravis: Controversies and Updates. CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 14(1). doi:10.1007/s11910-013-0421-9
2013
Telephone Assessment of the Expanded Disability Status Scale (P04.141)
Huda, S., & Palace, J. (2013). Telephone Assessment of the Expanded Disability Status Scale (P04.141). Neurology, 80(7_supplement). doi:10.1212/wnl.80.7_supplement.p04.141
An unusual cause of mononeuritis multiplex.
Huda, S., & Krishnan, A. (2013). An unusual cause of mononeuritis multiplex.. Practical neurology, 13(1), 39-41. doi:10.1136/practneurol-2012-000343
Asystole and facial pain.
Huda, S., Das, K., & Steiger, M. (2013). Asystole and facial pain.. Practical neurology, 13(1), 42-43. doi:10.1136/practneurol-2012-000372
Acetylcholine Receptor and Muscle-Specific Kinase Autoantibodies
Huda, S., & Vincent, A. (2013). Acetylcholine Receptor and Muscle-Specific Kinase Autoantibodies. In Autoantibodies Third Edition (pp. 575-580). doi:10.1016/B978-0-444-56378-1.00068-X
2012
090 The phenotype of Voltage Gated Potassium Channel (VGKC) antibody positive patients at the Walton Centre for neurology and neurosurgery. A retrospective analysis of 52 patients
Huda, S., Wong, S., & Steiger, M. J. (2012). 090 The phenotype of Voltage Gated Potassium Channel (VGKC) antibody positive patients at the Walton Centre for neurology and neurosurgery. A retrospective analysis of 52 patients. Journal of Neurology, Neurosurgery & Psychiatry, 83(3), e1.38-e1. doi:10.1136/jnnp-2011-301993.132
091 A forgotten cause of mononeuritis multiplex
Huda, S., Hunter, G., & Krishnan, A. (2012). 091 A forgotten cause of mononeuritis multiplex. Journal of Neurology, Neurosurgery & Psychiatry, 83(3), e1.39-e1. doi:10.1136/jnnp-2011-301993.133
Longitudinally extensive transverse myelitis as the sole presentation of neuro-Behcet's disease responding to infliximab
Coulter, I., Huda, S., Baborie, A., & Jacob, A. (2012). Longitudinally extensive transverse myelitis as the sole presentation of neuro-Behcet's disease responding to infliximab. JOURNAL OF SPINAL CORD MEDICINE, 35(2), 122-124. doi:10.1179/2045772311Y.0000000050
An unusual presentation of an epidermoid brain tumour: a tale of two specialties.
Wong, J. -J., Huda, S., & Wieshmann, U. C. (2012). An unusual presentation of an epidermoid brain tumour: a tale of two specialties.. BMJ case reports, 2012, bcr2012006546. doi:10.1136/bcr-2012-006546
Protracted neuroborreliosis--an unusual cause of encephalomyelitis.
Huda, S., & Wieshmann, U. C. (2012). Protracted neuroborreliosis--an unusual cause of encephalomyelitis.. BMJ case reports, 2012, bcr1120115206. doi:10.1136/bcr.11.2011.5206
2011
Retigabine add-on for refractory partial-onset seizures
Huda, S., Shukralla, A., & Marson, A. G. (2011). Retigabine add-on for refractory partial-onset seizures. Cochrane Database of Systematic Reviews. doi:10.1002/14651858.cd009368
2010
POC14 Treatment-resistant hyponatraemia
Huda, S., Tyne, H., & Marson, A. G. (2010). POC14 Treatment-resistant hyponatraemia. Journal of Neurology, Neurosurgery & Psychiatry, 81(11), e38. doi:10.1136/jnnp.2010.226340.84
POC25 B-cell non-Hodgkin lymphoma presenting with diplopia, ataxia, and subacute polyneuropathy: neoplastic vs paraneoplastic?
Huda, S., Tyne, H., & Iniesta, I. (2010). POC25 B-cell non-Hodgkin lymphoma presenting with diplopia, ataxia, and subacute polyneuropathy: neoplastic vs paraneoplastic?. Journal of Neurology, Neurosurgery & Psychiatry, 81(11), e41. doi:10.1136/jnnp.2010.226340.95
POC26 A protracted course of neuroborelliosis, the debate continues
Huda, S., Afzal, M. F., Tyne, H., & Wieshmann, U. C. (2010). POC26 A protracted course of neuroborelliosis, the debate continues. Journal of Neurology, Neurosurgery & Psychiatry, 81(11), e41. doi:10.1136/jnnp.2010.226340.96